Offer - Urjas Oil for just ₹ 1
Combisure 6 Mcg/250 Mcg Inhaler is a prescription medicine that is available as a Inhaler. Other than this, Combisure 6 Mcg/250 Mcg Inhaler has some other therapeutic uses, which have been discussed ahead.
Medical history of the patient along with age and gender determines the dosage of Combisure 6 Mcg/250 Mcg Inhaler. Individual symptoms and route of administration also determines the right dosage. Refer to the dosage section for a detailed discussion.
Common side effects of Combisure 6 Mcg/250 Mcg Inhaler include Nosebleed, Chest tightness, Cough. Besides the aforementioned side effects, there are other adverse effects of Combisure 6 Mcg/250 Mcg Inhaler as well, which are listed below. These side effects of Combisure 6 Mcg/250 Mcg Inhaler are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Combisure 6 Mcg/250 Mcg Inhaler has a Moderate effect for pregnant women and Mild effect on lactating mothers. In addition, Combisure 6 Mcg/250 Mcg Inhaler's effects on the liver, heart and kidney are discussed below in the Combisure 6 Mcg/250 Mcg Inhaler related warnings section.
Some other conditions that can be affected by Combisure 6 Mcg/250 Mcg Inhaler are listed in the contraindications section below.
Besides this, Combisure 6 Mcg/250 Mcg Inhaler may also have severe interaction with some medicines. Refer to the list below for further details.
You should also be aware that Combisure 6 Mcg/250 Mcg Inhaler is safe while driving, and is addiction.
Combisure 6 Mcg/250 Mcg Inhaler is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| 13 - 18 years (Adolescent) |
|
| Adult |
|
| Geriatric |
|
Is the use of Combisure 6 Mcg/250 Mcg Inhaler safe for pregnant women?
Combisure can have harmful effects in pregnant women. If you experience any discomfort after using Combisure, then discontinue the use and take your doctor's advice.
Is the use of Combisure 6 Mcg/250 Mcg Inhaler safe during breastfeeding?
Side effects of Combisure on breastfeeding women are very mild.
What is the effect of Combisure 6 Mcg/250 Mcg Inhaler on the Kidneys?
Using Combisure does not have any harmful effects on kidneys.
What is the effect of Combisure 6 Mcg/250 Mcg Inhaler on the Liver?
Combisure can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Combisure 6 Mcg/250 Mcg Inhaler on the Heart?
There may be an adverse effect on the heart after taking Combisure. If you observe any side effects on your body then stop taking this drug. Restart this medicine only if your doctor advises you to do so.
If you are suffering from any of the following diseases, you should not take Combisure 6 Mcg/250 Mcg Inhaler unless your doctor advises you to do so -
Is this Combisure 6 Mcg/250 Mcg Inhaler habit forming or addictive?
Combisure 6 Mcg/250 Mcg Inhaler is not addictive in nature.
Interaction between Food and Combisure 6 Mcg/250 Mcg Inhaler
Information is not available on the interaction of any foods with Combisure 6 Mcg/250 Mcg Inhaler, due to a lack of research on this.
Interaction between Alcohol and Combisure 6 Mcg/250 Mcg Inhaler
Information about the interaction of Combisure 6 Mcg/250 Mcg Inhaler and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Perforomist® (formoterol fumarate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 224
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 595-596
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Flonase (fluticasone propionate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 231
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 355-359
